National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, UK.
City Hospitals Sunderland NHS Foundation Trust, Faculty of Health Sciences, University of Sunderland, UK.
Best Pract Res Clin Obstet Gynaecol. 2019 Apr;56:93-106. doi: 10.1016/j.bpobgyn.2018.09.005. Epub 2018 Sep 29.
During the past decade, there has been an increase in the awareness of infections associated with pregnancy and delivery. The most significant cause of post-partum infection is caesarean section; 20-25% of operations are followed by wound infections, endometritis or urinary tract infections. Approximately 13% of women in the UK undergo operative vaginal delivery (OVD) with forceps or vacuum, which is also associated with an increased risk of infection, estimated at 0.7%-16% of these deliveries. Despite this, previous reviews have identified only one small trial of antibiotic prophylaxis in 393 women and concluded that there was insufficient evidence to support the routine use of prophylactic antibiotics after OVD. The ANODE trial, a multicentre, blinded, placebo-controlled trial from the UK, is due to report findings from more than 3400 women in 2019 and will be the largest study to date of antibiotic prophylaxis following OVD.
在过去的十年中,人们对与妊娠和分娩相关的感染的认识有所提高。导致产后感染的最主要原因是剖宫产术;20-25%的手术会出现伤口感染、子宫内膜炎或尿路感染。在英国,约有 13%的女性接受产道手术分娩(OVD),其中使用产钳或真空吸引器,这也会增加感染的风险,估计在这些分娩中有 0.7%-16%会出现感染。尽管如此,之前的综述只确定了一项针对 393 名女性的抗生素预防的小型试验,并得出结论,没有足够的证据支持 OVD 后常规使用预防性抗生素。英国的一项多中心、盲法、安慰剂对照试验——ANODE 试验预计将于 2019 年报告超过 3400 名女性的研究结果,这将是迄今为止最大规模的 OVD 后抗生素预防研究。